You have printed or saved this information from, the website for the Horizon Health Network

Facebook Icon LinkedIn Icon Twitter Icon Icon Icon
Print this page

Information and Recommendation on Zika Virus

The Zika virus has rapidly emerged as a disease of significant concern, especially for pregnant women and those who intent to get pregnant as it has recently been linked to microcephaly and other congenital anomalies. 

The Committee to Advise on Tropical Medicine and Travel (CATMAT) released  Canadian Recommendations on the Prevention and Treatment of Zika Virus, developed in conjunction with representatives from the Society of Obstetricians and Gynecologists of Canada and PHAC's National Microbiology Laboratory (NML). Please consult this important document:

Canadian recommendations on the prevention and treatment of Zika virus: Update (Volume 42-5 May 5, 2016) 

Additional resources can also be found below.

Please note, information and data on zika virus as well as recommendations for testing may change as the situation evolves. Please consult this page and the provided links on a regular basis.



CDC-Centers for Disease Control and Prevention

Society of Obstetricians and Gynecologists of Canada (SOGC)- Resources and latest guidance on Zika virus and pregnant women

PHAC- Information for health professionals

PHAC- general information

PHAC- Laboratory Testing Recommendations

Government of Canada- Travel Notice

Government of Canada -Countries with reported locally acquired Zika virus infection

Government of New Brunswick-Office of the Chief Medical Officer of Health-Letter to Health care Providers